NCT04320121

Effect of Nelutri™ on Musculoskeletal Biomarkers in Relative Sarcopenia Adults

Effect of Nelutri™ on Musculoskeletal Biomarkers in Relative Sarcopenia Adults: a Randomized, Double-blinded, Placebo-controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Pusan National University Yangsan Hospital · Academic / Other
• Sex: All
• Age: 19 Months
• Healthy volunteers: Accepted

Summary

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Nelutri™on muscle strength, muscle mass, and muscle function in healthy adults for 12 weeks.

Detailed description

A previous study has indicated that Nelutri™ may increase muscle mass and strength. Therefore, the investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Nelutri™on muscle strength, muscle mass, and muscle function in healthy adults; the safety of the compound are also evaluate. The Investigators examine the peak torque/body weight at 60°/s knee extension, handgrip strength, skeletal muscle mass, physical performance, and metabolic parameters at baseline, as well as after 6 and 12 weeks of intervention. Eighty adults were administered either 2,000 mg of Nelutri™ or a placebo each day for 12 weeks;

Conditions

• Muscular Sarcoidosis

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Nelutri™	Nelutri™ 2,000 mg/day for 12 weeks
DIETARY_SUPPLEMENT	Placebo group	Placebo 2,000 mg/day for 12 weeks

Timeline

• Start date: 2020-03-11
• Primary completion: 2020-12-30
• Completion: 2020-12-31
• First posted: 2020-03-24
• Last updated: 2021-04-28

Locations

1 site across 1 country: South Korea